Neuroscience 2022 by Society for Neuroscience

New preclinical data indicating Phase IIb drug candidate mesdopetam’s powerful efficacy in Parkinson’s psychosis and PD-LIDs will be presented in two scientific posters at the premier congress Neuroscience 2022 hosted by Society for Neuroscience in San Diego, CA, on November 12-16.

Neuroscience 2022 is the premier global neuroscience event and is organized by the Society for Neuroscience (SfN). Each year, tens of thousands of neuroscientists from around the world congregate to discover new ideas, share their research, and experience the best the field has to offer.

Read more here >